The FDA has launched an emergency program with the goal of expediting the development of safe, effective drugs to treat COVID-19.
The Coronavirus Treatment Acceleration Program is designed to bring new therapies to COVID-19 patients as quickly as possible while supporting research to determine whether those therapies are safe and effective.
The agency said there are 10 "therapeutic agents" to treat COVID-19 that are in active trials and another 15 that are in planning stages. The FDA will update the numbers as they change.
Read the full news release here.